Skip to main content
Erschienen in: MMW - Fortschritte der Medizin 6/2019

01.04.2019 | Echokardiografie | FORTBILDUNG . SCHWERPUNKT

Risikoprofil und Wunsch des Patienten entscheidend

Aortenklappenerkrankungen: Wann und wie sanieren?

verfasst von: Assoc. Prof. Dr. Jolanta M. Siller-Matula, Dr. Felix Hofer, Assoc. Prof. Dr. Georg Goliasch, Assoc. Prof. Dr. Martin Andreas, Univ. Prof. Dr. Julia Mascherbauer, Univ. Prof. Christian Hengstenberg

Erschienen in: MMW - Fortschritte der Medizin | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Durch die immer älter werdende Bevölkerung steigt die Prävalenz von Aortenklappenstenosen stetig an. Erste Warnsignale sind Belastungsdypnoe, Synkopen und Angina pectoris. Was bei V. a. Aortenklappenerkrankungen zu tun ist, erfahren Sie im nachfolgenden Beitrag.
Literatur
1.
Zurück zum Zitat Iung, B., et al., A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003. 24(13): p. 1231–43.CrossRef Iung, B., et al., A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003. 24(13): p. 1231–43.CrossRef
2.
Zurück zum Zitat Nkomo, V.T., et al., Burden of valvular heart diseases: a population-based study. Lancet, 2006. 368(9540): p. 1005–11.CrossRef Nkomo, V.T., et al., Burden of valvular heart diseases: a population-based study. Lancet, 2006. 368(9540): p. 1005–11.CrossRef
3.
Zurück zum Zitat Otto, C.M., et al., Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med, 1999. 341(3): p. 142–7.CrossRef Otto, C.M., et al., Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med, 1999. 341(3): p. 142–7.CrossRef
4.
Zurück zum Zitat Otto, C.M., Calcific aortic stenosis—time to look more closely at the valve. N Engl J Med, 2008. 359(13): p. 1395–8.CrossRef Otto, C.M., Calcific aortic stenosis—time to look more closely at the valve. N Engl J Med, 2008. 359(13): p. 1395–8.CrossRef
5.
Zurück zum Zitat Baumgartner, H., et al., 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, 2017. 38(36): p. 2739–2791.CrossRef Baumgartner, H., et al., 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, 2017. 38(36): p. 2739–2791.CrossRef
6.
Zurück zum Zitat Baumgartner, H., et al., Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr, 2017. 30(4): p. 372–392.CrossRef Baumgartner, H., et al., Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr, 2017. 30(4): p. 372–392.CrossRef
7.
Zurück zum Zitat Wilkenshoff, U.K., Irmtrau, Handbuch der Echokardiografie. 2011: Thieme Verlag KG. Wilkenshoff, U.K., Irmtrau, Handbuch der Echokardiografie. 2011: Thieme Verlag KG.
8.
Zurück zum Zitat Ponikowski, P., et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016. 37(27): p. 2129–2200.CrossRef Ponikowski, P., et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016. 37(27): p. 2129–2200.CrossRef
9.
Zurück zum Zitat le Polain de Waroux, J.B., et al., Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography. Circulation, 2007. 116(11 Suppl): p. I264–9.PubMed le Polain de Waroux, J.B., et al., Functional anatomy of aortic regurgitation: accuracy, prediction of surgical repairability, and outcome implications of transesophageal echocardiography. Circulation, 2007. 116(11 Suppl): p. I264–9.PubMed
10.
Zurück zum Zitat Lansac, E., et al., A lesional classification to standardize surgical management of aortic insufficiency towards valve repair. Eur J Cardiothorac Surg, 2008. 33(5): p. 872–8; discussion 878-80.CrossRef Lansac, E., et al., A lesional classification to standardize surgical management of aortic insufficiency towards valve repair. Eur J Cardiothorac Surg, 2008. 33(5): p. 872–8; discussion 878-80.CrossRef
11.
Zurück zum Zitat Freeman, L.A., et al., CT and MRI assessment of the aortic root and ascending aorta. AJR Am J Roentgenol, 2013. 200(6): p. W581–92.CrossRef Freeman, L.A., et al., CT and MRI assessment of the aortic root and ascending aorta. AJR Am J Roentgenol, 2013. 200(6): p. W581–92.CrossRef
12.
Zurück zum Zitat Elder, D.H., et al., The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol, 2011. 58(20): p. 2084–91.CrossRef Elder, D.H., et al., The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol, 2011. 58(20): p. 2084–91.CrossRef
13.
Zurück zum Zitat Zendaoui, A., et al., Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation. Circ Heart Fail, 2011. 4(2): p. 207–13.CrossRef Zendaoui, A., et al., Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation. Circ Heart Fail, 2011. 4(2): p. 207–13.CrossRef
14.
Zurück zum Zitat Habib, G., et al., 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J, 2015. 36(44): p. 3075–3128.CrossRef Habib, G., et al., 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J, 2015. 36(44): p. 3075–3128.CrossRef
15.
Zurück zum Zitat Chaliki, H.P., et al., Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation, 2002. 106(21): p. 2687–93.CrossRef Chaliki, H.P., et al., Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation, 2002. 106(21): p. 2687–93.CrossRef
16.
Zurück zum Zitat Tornos, P., et al., Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery. J Am Coll Cardiol, 2006. 47(5): p. 1012–7.CrossRef Tornos, P., et al., Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery. J Am Coll Cardiol, 2006. 47(5): p. 1012–7.CrossRef
17.
Zurück zum Zitat Sambola, A., et al., Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. Am Heart J, 2008. 155(6): p. 1114–20.CrossRef Sambola, A., et al., Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. Am Heart J, 2008. 155(6): p. 1114–20.CrossRef
18.
Zurück zum Zitat Andreas, M., et al., Minimalinvasiver Aortenklappenersatz über eine anteriore rechtsseitige Thorakotomie. Z Herz- Thorax- Gefäßchir, 2017. 31(4): p. 241–246.CrossRef Andreas, M., et al., Minimalinvasiver Aortenklappenersatz über eine anteriore rechtsseitige Thorakotomie. Z Herz- Thorax- Gefäßchir, 2017. 31(4): p. 241–246.CrossRef
19.
Zurück zum Zitat Kocher, A., et al., Minimally invasive aortic valve replacement through an upper hemisternotomy: the Vienna technique. Eur J Cardiothorac Surg, 2018. 53(suppl_2): p. ii29–ii31.CrossRef Kocher, A., et al., Minimally invasive aortic valve replacement through an upper hemisternotomy: the Vienna technique. Eur J Cardiothorac Surg, 2018. 53(suppl_2): p. ii29–ii31.CrossRef
20.
Zurück zum Zitat Kocher, A.A., et al., One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg, 2013. 145(1): p. 110–5; discussion 115-6.CrossRef Kocher, A.A., et al., One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg, 2013. 145(1): p. 110–5; discussion 115-6.CrossRef
21.
Zurück zum Zitat Andreas, M., et al., The Ross procedure offers excellent survival compared with mechanical aortic valve replacement in a real-world setting. Eur J Cardiothorac Surg, 2014. 46(3): p. 409–13; discussion 413-4.CrossRef Andreas, M., et al., The Ross procedure offers excellent survival compared with mechanical aortic valve replacement in a real-world setting. Eur J Cardiothorac Surg, 2014. 46(3): p. 409–13; discussion 413-4.CrossRef
22.
Zurück zum Zitat Andreas, M., et al., A single-center experience with the ross procedure over 20 years. Ann Thorac Surg, 2014. 97(1): p. 182–8.CrossRef Andreas, M., et al., A single-center experience with the ross procedure over 20 years. Ann Thorac Surg, 2014. 97(1): p. 182–8.CrossRef
Metadaten
Titel
Risikoprofil und Wunsch des Patienten entscheidend
Aortenklappenerkrankungen: Wann und wie sanieren?
verfasst von
Assoc. Prof. Dr. Jolanta M. Siller-Matula
Dr. Felix Hofer
Assoc. Prof. Dr. Georg Goliasch
Assoc. Prof. Dr. Martin Andreas
Univ. Prof. Dr. Julia Mascherbauer
Univ. Prof. Christian Hengstenberg
Publikationsdatum
01.04.2019
Verlag
Springer Medizin
Erschienen in
MMW - Fortschritte der Medizin / Ausgabe 6/2019
Print ISSN: 1438-3276
Elektronische ISSN: 1613-3560
DOI
https://doi.org/10.1007/s15006-019-0358-2

Weitere Artikel der Ausgabe 6/2019

MMW - Fortschritte der Medizin 6/2019 Zur Ausgabe

AUS DER PRAXIS VON HAUSARZT ZU HAUSARZT

Rechtsrisiko durch Migranten ohne Deutschkenntnisse

AKTUELLE MEDIZIN MAGAZIN

Jedes Glas ist ein Glas zu viel

AKTUELLE MEDIZIN . REPORT

Bluthochdruck durch Feierabendbier

Passend zum Thema

ANZEIGE

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

ANZEIGE

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

ANZEIGE

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Abbott Medical GmbH